Bronson Methodist Hospital: A systematic approach to validating xylene free processing on the Leica PELORIS tissue processor.



Similar documents
FULLY AUTOMATED PARALLEL DUAL STAINING DETECTION SYSTEM. ChromoPlex 1 Dual Detection for BOND

Leica CEREBRO Sample Tracking. Patient Safety. Enhanced Productivity. Complete Flexibility.

BREAST CANCER PATHOLOGY

VENTANA Digital Pathology. Reliable. Efficient. Comprehensive.

The Diagnosis of Cancer in the Pathology Laboratory

Streamlining the PATH Line: Onboarding Barcoding in Anatomic Pathology. By: Ary Franklin, HT(ASCP) & Carol Beth Taylor, MHS, PA/HTL(ASCP), GBLSS

PSA Screening for Prostate Cancer Information for Care Providers

MIRAX SCAN The new way of looking at pathology

Delphic AP. Designer software for your pathology workflow. We Believe the Possibilities.

We Believe the Possibilities. Delphic AP

1st NordiQC Conference on Standardization in Applied Immunohistochemistry

Early Prostate Cancer: Questions and Answers. Key Points

Patient Support Guide

Beyond the PSA: Genomic Testing in Localized Prostate Cancer

Norton Healthcare partners with Ortho Clinical Diagnostics to transform laboratory performance... for the long-term.

ab StayBlue/AP Plus Stain Kit Instructions for Use An immunohistochemical chromogen substrate for staining tissue sections

CONTENTS: WHAT S IN THIS BOOKLET

Understanding your pathology report

Case Study Building a Patient Safety-Centered AP Lab

IHC Service Center. Department of Medicine

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?

ProPath selects LKConnect

White paper Evaluation of BRAF (V600E) Mutation by Immunohistochemical Staining with anti-braf V600E (VE1) Antibody: A Comparison with Sanger

Put all your results in one basket. Orchard Pathology simplifies the complexities of clinical, molecular, and pathology testing and reporting.

Problem Management Why and how? Author : George Ritchie, Serio Ltd george dot- ritchie at- seriosoft.com

Automated Library Preparation for Next-Generation Sequencing

How to Overcome the Top Ten Objections in Credit Card Processing

STATE OF MICHIGAN DEPARTMENT OF INSURANCE AND FINANCIAL SERVICES Before the Director of Insurance and Financial Services

What is special about a stain, and why do we call some stains

Clinical Histology Procedure histo Embedding Paraffin Processed Tissue

Basic User Guide. Document Number D09665 Revision 01 July, For In Vitro Diagnostic Use

Applying to Physical Therapy Schools. Alyssa Montanaro Feel free to have any CMU students contact me with questions or advice.

Histology Asset Tracking March 3, 2013

Clinical Histology Procedure Histo03.01 Automated Immunohistochemical Staining Utilizing the Ventana Benchmark Instrument

Clinical Histology Procedure histo13.01 Automated Immunohistochemical Staining Utilizing the Bond III Instrument

Common Cancers & Hereditary Syndromes

Three Attributes of Every Successful Merchant Services Program

BioPATH: A Study of Biomarker Profiles in Asia Pacific HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-HER2 Therapy

Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma

IBCSG Tissue Bank Policy

Reducing Unscheduled Downtime and Customer Efficiency

PSA screening in asymptomatic men the debate continues keyword: psa

Field Notification Package for V 17A Software for the STP 420D/ES Tissue Processor

Opportunities and Challenges in Translating Novel Discoveries into Useful Clinical Tests

Affiliated Dermatology : A Practice with a Technology Focus and Family at Heart

PATHOLOGY. HercepTestTM. Product Information

How prostate cancer is diagnosed

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?

JOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR. 2nd Edition

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Error Reduction and Prevention in Surgical Pathology. Raouf E. Nakhleh, MD Professor of Pathology Mayo Clinic Florida

Immunohistochemistry. Services & Products. Indivumed GmbH Falkenried 88, Bldg. D Hamburg Germany

Cancer: DNA Synthesis, Mitosis, and Meiosis

Finnish Cancer Registry Institute for Statistical and Epidemiological Cancer Research. Survival ratios of cancer patients by area in Finland

If you are signing for a minor child, you refers to your child throughout the consent document.

Improving Employee Satisfaction in Healthcare through Effective Employee Performance Management

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Cancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Questions to Ask My Doctor About Prostate Cancer

C a nc e r C e nter. Annual Registry Report

Best Practice Partnership Program

How To Get A Cell Print

Interoperability between Anatomic Pathology Laboratory Information Systems and Digital Pathology Systems

Understanding Lynch Syndrome

What is cancer? Teacher notes. Key stage 4/4 TH LEVEL Science lesson plan with links to PSHE

The 3 Biggest Mistakes Investors Make When It Comes To Selling Their Stocks

LUNG CANCER CLINICAL TRIALS

Accounting Basics. (Explanation)

EXECUTIVE HEALTH EXAM

3D- Cam FPV User Guide. April, Rev. 0.2

Seven Things You Must Know Before Hiring a DUI Attorney

Introduction to Open Atrium s workflow

HOW TO RIDE A 10-PERSON BICYCLE Improving Employee Engagement in Real-Time

Steps To Better Histology. Scientia. Leica Microsystems Education Series

NOVEL PLATFORMS FOR CANCER DIAGNOSIS

EZValidation Online Tool. The easy way to apply guidelines. The EZValidation Online Tool. The implementation of new tests

How To Know If You Have Cancer At Mercy Regional Medical Center

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

How to Design an Employee Engagement Survey

PATHOLOGY DEPARTMENTS AT GRADUATE MEDICAL EDUCATION TEACHING INSTITUTIONS

How To Manage An Itil Service Manager

Chapter 28 LIQUIDATION

Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns

Transcription:

Bronson Methodist Hospital: A systematic approach to validating xylene free processing on the Leica PELORIS tissue processor. In 2010, the pathology laboratory at Bronson Methodist Hospital (BMH) in Kalamazoo, Michigan looked to enhance patient care in their laboratory by switching from conventional xylene processing to rapid xylene free processing using the Leica PELORIS tissue processor. Before adopting the new process for all clinical work, they undertook an extensive six month evaluation of xylene free processing. These validation trials established the effectiveness of xylene free processing for both routine and IHC staining and BMH have now been successfully processing their entire caseload xylene free for over 12 months. Leica PELORIS introduces Lean workflows The Bronson Methodist Hospital first looked to Leica PELORIS to improve their histology workflow. According to Dr. Jeff Pearson, Pathology Department Medical Director, they had conventional old fashioned process and were doing the old approach of batching all of our histology specimens for overnight processing. The problem with that was in the morning we d have pathologists waiting for cases to read and then between 11:00 and 12:00, we d get all kinds of trays more than we could handle. The solution was to use the rapid, dual retort Leica PELORIS tissue processor to instigate continuous processing and 24 hour turnaround. Dr. Pearson is proud of the improvements this has made for histotechs, pathologists and patient care: The PELORIS was set up for multiple runs every day. Now slides come out at a steady interval so we can read continuously

without getting backed up. Pathologists like it better and histotechs do too. We get approximately 95% of non decal cases signed out within 24 hours. No one else can do that. Clinicians tell me that our turnaround time is much better than [other laboratories ]. They noticed because [24 hour turnaround] allows them to complete a case in their mind, because if you get results the next day, you remember that patient. The pathology laboratory s Director, Lois Van Enk, who was the laboratory manager during the early testing of Leica PELORIS, summed up the advantages of the new workflow as: a dramatic improvement in our patient care and turnaround, in customer satisfaction to clinicians and for that patient waiting on the other end for the call on their biopsy. Exploring xylene free processing The BMH laboratory had many reasons to try xylene free processing. The department has a green, eco friendly mentality and the laboratory also wanted to reduce staff exposure to xylene. Their main concern though was patient safety which made them initially cautious. To fully validate the process for clinical diagnostic use would require a side by side comparison with xylene processed tissue. Dr. Pearson explains It was the great unknown. Is this going to work or not? We wanted to do it for safety and eco green reasons, and we couldn t do it until we had two processors to run and compare them side by side. Fortunately, as Dr. Pearson explains, Lois had the foresight to say, Hey, we need a second one. We were so pleased with the processing ability we wanted a second instrument so that we wouldn t have to use a conventional processor at all. So when BMH received delivery of a second Leica PELORIS in early 2010, they were able to instigate a very careful plan to validate the suitability of xylene free processing for their clinical work. Proceeding carefully Before BMH would adopt xylene free processing for clinical diagnosis they wanted to be absolutely sure that the process would not damage or degrade any tissue types. So initial small scale testing was done with excess tissue. Dr. Pearson explains: We were nervous and anxious, and we took it very slowly. So we started out with excess tissues, a placenta or colon, to test it out, and didn t see any difference, it worked fine. The next step was to do side to side comparisons with real cases. Initially using one cassette from a case to test xylene free processing, for example one cassette out of twenty for a whole breast cancer case. Then, as their confidence grew and the results were encouraging, more cassettes were put through the xylene free process with cases being split between xylene and xylene free. According to Dr. Pearson : for a TURP, where you re looking at prostate chips, we d split them up and do four cassettes conventional processing, four cassettes xylene-free. Top (left to right): Lois Van Enk, Dr. Jeff Pearson and Virginia Rupert. Bottom (left to right): Kim Peterson with Sarah Langworthy.

Encouraging results Over the next five months, more and more tissue was processed xylene free, the processing quality continued to be comparable to conventional xylene processing. The laboratory continued to increase their xylene free experience with not only routine staining, but also IHC slides, comparing xylene to xylene free For breast cancer cases, the laboratory processed ER, PR, and HER2 neu using both xylene and xylene-free protocols then compared the results and: never saw the slightest bit of difference. Dr. Pearson was not surprised that xylene free results were comparable to xylene as: it doesn t affect the fixation. You re still using formalin fixed, paraffin embedded tissue. So intuitively, you wouldn t expect that to change antigenicity at all, and it didn t in any way. Superior sectioning While the xylene free staining results continued to be indistinguishable from the xylene processed sections, the laboratory did notice one change the xylene free sections were actually easier to section. Senior Pathology Technician, Virginia Rupert explains that: the histotechnicians would basically dual for the xylene free trays because they were easier to cut. Dr. Pearson concurs saying that the improvement was across all tissue types: but you really notice it on little biopsies with your prostate needles and colon biopsies. Long term validation In total, the BMH validation process lasted for seven months. All types of tissue were processed xylene free and many different stains used. In all, 9638 cases had samples processed xylene free and all sections from xylene free blocks were at least equal in quality to the xylene processed equivalent. During the parallel processing period, Virginia Rupert explained how they sent trays to pathologists marked: xylene or xylene free because we wanted them to report back adverse effects. Throughout months of testing the laboratory staff kept waiting for something to go wrong or for someone to say, You re HER 2neu FISH doesn t work or Your MSI test in your colon cancer doesn t work. But it never happened and eventually, as Dr. Pearson states, the team at BMH realized it was better we actually realized that [xylene free] was superior. On going success On November 10, 2010 BMH switched all tissue processing to xylene free on the Leica PELORIS. Since that time they continue to successfully process around 1500 cassettes per week and the results from the long validation trial have been confirmed with no quality issues found. The blocks continue to be easier to cut with the histotechnicians reporting that overall tissue is not as brittle and blocks don t need to soak for as long. BMH have also experienced no issues with instrument reliability due to the xylene free process. With 12 months of clinical use, BMH has confirmed that the xylene free process does not have a negative affect on molecular testing. Dr. Pearson stated We ve never had any failures when we send those out for testing. It s never affected the rate of positivity for either HER 2neu or ERPR; stayed exactly the same. Xylene free validation trial Duration: 7 months Cases: 9638 Blocks: approx 11,000 xylene free blocks compared to 11,000 corresponding xylene blocks Stains: Routine, IHC and molecular (external staining) Tissue types: IHC antibodies: ER, PR, HER2neu, CD45, CD20, OSCAR, CD3, PIN 4, PSA, CK7, CK20, CDX2, PMS2, MSH2, MSH6 MLH1, MSI panel,, P53 and others. PCR (conducted by external ref labs): HER2 FISH, ALK1 FISH, Oncotype, EGFR and BRAF mutations. Results: Quality of all xylene free sections were at least equivalent to xylene processed sections Xylene free sections were easier to section Xylene free protocols These are the xylene free protocols BMH uses for various tissue types. All are Leica recommended protocols except for the 1.5 hour protocol which is BMH s shortened version of the Leica 2 hour protocol.

BMH xylene-free protocols 1.5 hr protocol 4 hr protocol 8 hr protocol 12 hr protocol temp [ C] time [s] temp [ C] time [s] temp [ C] time [s] temp [ C] time [s] formalin 45 5 55 10 55 30 55 68 85% ETOH Ambient 1 Ambient 3 55 20 55 30 85% ETOH 55 9 55 22 55 30 55 40 80/20 Ambient 1 Ambient 10 55 30 55 50 80/20 55 12 55 40 55 60 55 90 IPA Ambient 1 Ambient 3 55 20 55 30 IPA Ambient 1 55 10 55 40 55 60 IPA 55 16 55 45 55 80 55 120 WAX 85 23 85 45 85 60 85 80 WAX 85 6 85 20 85 50 85 70 WAX 65 2 65 10 65 40 65 60 H&E staining protocols Protocols used by BMH on their Leica ST5020 Multistainer. step reagent hh:mm:ss exact dip 1 oven 0:07:30 no no 2 oven 0:07:30 no no 3 xylene 0:02:00 no no 4 xylene 0:02:00 no no 5 ETOH 100% 0:00:11 no yes 6 ETOH 100% 0:01 :30 no yes 7 ETOH 95% 0:00:11 no yes 8 ETOH 95% 0:01 :30 no yes 9 DI water 0:01 :00 no no 10 Hematoxylin 0:01 :30 yes yes 11 DI water 0:02:00 no yes 12 Clarifier 0:00:30 yes yes 13 DI water 0:02:00 no yes 14 Bluing 0:00:30 yes no 15 DI water 0:02:00 no no 16 ETOH 95% 0:01 :30 no yes 17 EOSIN 0:00:30 yes yes 18 ETOH 100% 0:00:11 no yes 19 ETOH 100% 0:00:11 no yes 20 ETOH 100% 0:02:00 no yes 21 ETOH 100% 0:02:00 no yes 22 xylene 0:00:11 no yes 23 xylene 0:00:11 no yes 24 xylene 0:02:00 no yes 25 xylene 0:02:00 no yes

Stain scoring sheet examples During the trial stage, BMH kept extensive scoring worksheets to confirm the quality of xylene free processing. BRONSON METHODIST HOSPITAL DEPARTMENT OF PATHOLOGY/HISTOLOGY LABORATORY INSTRUMENT VALIDATION SHEET INSTRUMENT_PELORIS SERIAL No: 0260369B Added an additional section to be processed on a xylene-free program to then be compared after sectioning to our xylene processed tissue. The results were favorable In all cases DATE INT TEST RAN ACCEPTABLE? Case No. Tissue COMMENTS/ 5/19/2010 kp 8hr factory protocol 5/19/2010 kp 4 hr factory protocol Yes/No s510-9873 -1 Intervertebral disc Yes/No s510-9882 - Al left paranasal sinum bx Yes/No 510-9929 1-3,6 rt hemicolectomy Yes/No 510-9945 - Al, A2 colon Yes/No sl0-9948 - As, A4, prostatectomy A6, A6, Al0, A12, A14, A16, A18, A20 Yes/No 810-9950 - 2, 4 small intestine Yes/No 810-9952 -1 gall bladder Yes/No 810-9956 -1 appendix Yes/No 810-9965 -2 urinary bladder Yes/No 810-9966 -1 gall bladder Yes/No 810-9974 -1,2 endometrium Yes/No 810-9988 -B2 jejunum Yes/No 810-9990 -1 gall bladder Yes/No 810-9992 - B4 rt breast Yes/No 810-9995-A4 sigmoid colectomy Yes/No 810-9995 -Bl appendix Yes/No 810-9996 -1 left knee Yes/No 810-10002 -1 gall bladder Yes/No s10-10031 endometrium Yes/No s10-10041 A endometrium Yes/No s10-10041 C cervix Yes/No 510-10043 uterine contents Yes/No 510-10044 lung biopsy Yes/No s10-10047 vaginal/mucosa CORRECTIVE ACTIONS

Going Green. Part of the initial impetus to switch to xylene free processing came from the BMH Builds Green program. Bronson Builds Green! Bronson strives to create a healthy, healing environment for patients, staff and the community through pollution prevention, energy conservation and sustainable building design. Eighty nine percent of the materials from the demolition of the north tower were recycled. Here are some other choices Bronson has made to continue its focus of building green in the new North Pavilion: Flooring made from petroleum free materials (carpet, rubber) PVC free products Energy efficient windows Low emitting materials like adhesives, sealants, paints, composite woods Using local and regional vendors to decrease transportation impact Energy efficient infrastructure Healing gardens and natural light Exploring green roof options 95.10805 Rev A 03/2012 Copyright by Leica Biosystems, Melbourne, Australia, 2012. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.